SCHEMBL13490485

SCHEMBL13490485

CCc1ccc(C2=CCCN(C(=O)OCc3ccccc3)C2)nc1/N=C\ON

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TMEM97 Q5BJF2 10/20 0.37
SIGMAR1 Q99720 10/20 0.37
CYP2C19 P33261 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
GRM5 P41594 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
DRD1 P21728 1/20 0.35
HRH2 P25021 1/20 0.35
HTR1B P28222 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171517 0.84 DHFR (0.47) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL14544156 0.80 SMN1; SMN2 (0.42) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL13490483 0.76 CYP1A2 (0.50) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL171466 0.76 MEN1 (0.44) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL13490591 0.74 MEN1 (0.38) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL13490472 0.74 MEN1 (0.43) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL13490590 0.73 MEN1 (0.44) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL169428 0.72 GRM5 (0.50) DHFRSMN1; SMN2NPC1RAB9ATMEM97
SCHEMBL171515 0.71 KDM1A (0.43) SMN1; SMN2NPC1RAB9ATMEM97SIGMAR1
SCHEMBL13490572 0.71 P2RY12 (0.43) SMN1; SMN2NPC1RAB9ATMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530662-B2 Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them FUJIFILM FINECHEMICALS CO., LTD (JP) 2013-09-10 US disclosed
US-8530662-B2 Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them FUJIFILM FINECHEMICALS CO., LTD (JP) 2013-09-10 US disclosed
US-20100029947-A1 Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them FUJIFILM FINECHEMICALS CO., LTD 2010-02-04 US disclosed
US-7632950-B2 Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them FUJIFILM FINECHEMICALS CO., LTD (JP) 2009-12-15 US disclosed
US-20070093528-A1 Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them FUJIFILM FINECHEMICALS CO., LTD (JP) 2007-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029947-A1 Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them QDPR, HRH4, HRH2 DHFR 69/4885SMN1; SMN2 4714/4885NPC1 4762/4885
US-20070093528-A1 Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them QDPR, HRH4, HRH2 DHFR 57/4885SMN1; SMN2 4779/4885NPC1 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.